Approach to Pediatric Intractable Migraine

Mohammed Alqahtani1, Rebecca Barmherzig2, Ana Marissa Lagman-Bartolome3,4

  • 1Division of Neurology, The Hospital for Sick Children, 555 University Avenue, Toronto, Ontario, M5G 1X8, Canada.

Insights

Intractable migraine in children significantly impacts quality of life. This review outlines a comprehensive management approach, including acute and preventive therapies for pediatric intractable migraine.

Area of Science:

  • Pediatric Neurology
  • Headache Medicine
  • Quality of Life Research

Background:

  • Intractable migraine in children and adolescents causes significant disability and reduced quality of life (QoL).
  • Current management strategies often rely on adult data or expert consensus due to limited pediatric-specific research.
  • A lack of a unifying definition for intractable migraine complicates diagnosis and treatment.

Purpose of the Study:

  • To review current best-practice approaches for evaluating and managing intractable migraine in pediatric populations.
  • To present evidence-based and consensus-driven strategies for acute and preventive therapy.
  • To highlight the importance of a comprehensive approach including diagnosis, risk factor management, and adaptive coping strategies.

Main Methods:

  • Descriptive review of available literature on pediatric intractable migraine management.
  • Focus on outpatient, emergency department (ED), and inpatient treatment strategies.
  • Consideration of clinical data, safety, tolerability, cost-effectiveness, and expert consensus.

Main Results:

  • A comprehensive approach involves excluding secondary causes, accurate diagnosis, managing modifiable risk factors, and initiating pharmacologic therapy.
  • Management strategies include acute medications, bridge therapy, emerging preventive therapies, and stepwise combination therapy.
  • Treatment aims to reduce disability, improve QoL, prevent progression, and develop pain coping strategies.

Conclusions:

  • Effective management of pediatric intractable migraine requires a multidisciplinary and stepwise approach.
  • Evidence-based strategies and expert consensus guide the treatment of acute and preventive aspects of this condition.
  • Optimizing treatment can significantly improve outcomes and quality of life for affected children and adolescents.
Abstract

Related Concept Videos

Drug Delivery: Parenteral Route01:29

Drug Delivery: Parenteral Route

The parenteral route is a critical method of drug administration. It delivers compounds directly into the systemic circulation and bypasses the gastrointestinal tract. This approach is particularly advantageous for drugs that exhibit poor absorption or instability when administered orally.
There are three primary parenteral routes: intravenous (IV), intramuscular (IM), and subcutaneous (SC). The IV route introduces the drug directly into the bloodstream, ensuring immediate action. The IM route...
1.1K
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
55
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
49